Epocrates: PDA medical software

Recent Updates

August 25, 2010

MedWatch Safety Alert for Stalevo
The FDA recently notified healthcare professionals that patients taking Stalevo (carbidopa/levodopa/entacapone) may be at increased risk for cardiovascular events, compared to patients taking Sinemet (carbidopa/levodopa). Patients taking Stalevo should have their cardiovascular status regularly evaluated, especially if they have a history of cardiovascular disease. MedWatch Safety Alert for Stalevo »

August 18, 2010/dt>

MedWatch Safety Alert for Lamictal
The product labeling for Lamictal (lamotrigine) has been revised to include information about aseptic meningitis associated with the use of the drug. Lamictal is commonly used to treat seizures in children and adults and bipolar disorder in adults. Patients being treated with Lamictal should be monitored for symptoms of meningitis, including headache, fever, stiff neck, nausea, vomiting, rash, and sensitivity to light. MedWatch Safety Alert for Lamictal »

August 11, 2010

Influenza Vaccine Updates
Based on the CDC’s Advisory Committee on Immunization Practices (ACIP) recommendations for the 2010-11 season, the influenza vaccine monographs for Afluria, Agriflu, Fluarix, FluLaval, FluMist, Fluvirin, Fluzone, and Fluzone High-Dose, as well as the adult and pediatric vaccination tables, have been updated. The ACIP is recommending that all persons aged greater than or equal to 6 months be vaccinated; children between 6 months and 8 years who were inadequately vaccinated for the seasonal or H1N1 influenza in 2009-10 should receive 2 doses of the influenza vaccine in 2010-11; and trivalent vaccines containing A/California/7/2009 (H1N1)-like, A/Perth/16/2009 (H3N2)-like, and B/Brisbane/60/2008-like antigens should be used. Influenza Vaccine Updates »